THE STARTUPS DESK
The companies, products and decisions changing how businesses are built.
12 stories to explore
The Toothsi parent’s new round supports facilities, technology and clinics. Network growth needs a clear boundary between commercial reach and clinical responsibility.
The certification business is expanding its team and geographic reach. Faster administration has value only when the underlying decision remains defensible.
Ascensia is backing the sensor developer. Funding, manufacturing readiness and regulatory clearance remain separate steps.
The research spinout is developing tools for drug developers and manufacturers. Its commercial challenge goes beyond producing a persuasive laboratory result.
The trapped-ion company’s Series A backs a modular approach. Funding validates investor appetite; useful computation still needs its own evidence.
The new office is a modest but revealing distribution move. Proximity can support enterprise adoption; it does not establish a contract win.
The lab-grown jewellery brand has announced $380,000 in funding. Repeat wear and customer trust are the more interesting business questions.
Workplace meals offer a different marketplace problem from consumer delivery: fewer spontaneous purchases, more coordination, and a buyer who expects accountability.
The company proposes subsidising home repairs while recording skilled work. The business hinges on whether useful demonstrations can be collected with clear boundaries and consent.
Portable ECG technology can make a test easier to perform. The business challenge is connecting the result to a reliable clinical workflow.
Google has widened access to its media verification tool. For startups, the useful question is how evidence of origin changes the product workflow.
Amazon says Ring’s first smart lock will include a manual power dial. The design offers a broader lesson for connected-device startups.
